Spyre Therapeutics
SYRE
#4826
Rank
ยฃ1.18 B
Marketcap
ยฃ23.13
Share price
-6.62%
Change (1 day)
165.85%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of ยฃ0.69 Million a decrease over the revenue in the year 2022 that were of ยฃ1.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 ยฃ0.69 M-63.87%
2022 ยฃ1.92 M-86.13%
2021 ยฃ13.88 M
2020 N/A
2019 N/A-100%
2018 ยฃ3.06 M-20.45%
2017 ยฃ3.85 M2.66%
2016 ยฃ3.75 M-8.66%
2015 ยฃ4.1 M
2014 N/A